HPLC analysis of asymmetric dimethylarginine (ADMA) and related arginine metabolites in human plasma using a novel non-endogenous internal standard

Clinica Chimica Acta

Volumn 401, Issue 1-2, 2009, Pages 14-19

  Blackwell, Scott ^a   O'Reilly, Denis St J ^a   Talwar, Dinesh K ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

ADMA; HPLC; Novel internal standard; SDMA; Validation

Indexed keywords

3 MERCAPTOPROPIONIC ACID; ARGININE; ARGININE DERIVATIVE; HOMOARGININE; MONOETHYLARGININE; MONOMETHYLARGININE; N(G),N(G) DIMETHYLARGININE; PHTHALALDEHYDE; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PRIORITY JOURNAL; REFERENCE VALUE; REVERSED PHASE LIQUID CHROMATOGRAPHY; SOLID PHASE EXTRACTION; SPECTRAL SENSITIVITY; STANDARD;

ARGININE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; REFERENCE STANDARDS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOLID PHASE EXTRACTION;

EID: 58549110015     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2008.10.032     Document Type: Article

References (44)

1. Fliser D. Asymmetric dimethylarginine (ADMA): the silent transition from an 'uraemic toxin' to a global cardiovascular risk molecule. Eur J Clin Invest 35 (2005) 71-79
2. Böger R.H. Asymmetric dimethylarginine (ADMA) and cardiovascular disease: insights from prospective clinical trials. Vasc Med 10 (2005) S19-S25
3. Vallance P., Leone A., Calver A., Collier J., and Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339 (1992) 572-575
4. Tran C.T., Leiper J.M., and Vallance P. The DDAH/ADMA/NOS pathway. Atheroscler Suppl 4 (2003) 33-40
5. + carrier hCAT-2B. Nitric Oxide 1 (1997) 65-73
6. Kielstein J.T., Salpeter S.R., Bode-Böger S.M., Cooke J.P., and Fliser D. Symmetric dimethylarginine (SDMA) as an endogenous marker of renal function - a meta-analysis. Nephrol Dial Transplant 21 (2006) 2446-2451
7. Bode-Böger S.M., Scalera F., Kielstein J.T., et al. Symmetrical dimethylarginine: a new combined parameter for renal function and the extent of coronary artery disease. J Am Soc Nephrol 17 (2006) 1128-1134
8. Achan V., Broadhead M., Malaki M., et al. Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase. Arterioscler Thromb Vasc Biol 23 (2003) 1455-1459
9. Cooke J.P. The pivotal role of nitric oxide for vascular health. Can J Cardiol 20 Suppl B (2004) 7B-15B
10. Schwedhelm E. Quantification of ADMA: analytical approaches. Vasc Med 10 (2005) S89-S95
11. Teerlink T. Determination of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine in biological samples by HPLC. Methods Mol Med 108 (2005) 263-274
12. G′ dimethyl-l-arginine in plasma by liquid chromatography as AccQ-Fluor™ fluorescent derivatives. J Chromatogr B 805 (2004) 325-329
13. Zhang W., and Kaye D.M. Simultaneous determination of arginine and seven metabolites in plasma by reversed-phase liquid chromatography with a time controlled ortho-phthaldialdehyde precolumn derivatization. Anal Biochem 326 (2004) 87-92
14. Marra M., Bonfigli A.R., Testa R., Gambini A., and Coppa G. High-performance liquid chromatographic assay of asymmertric dimethylarginine, symmetric dimethlarginine, and arginine in human plasma by derivatization with naphthalene-2,3-dicarboxaldehyde. Anal Biochem 318 (2003) 13-17
15. Teerlink T., Nijveldt R.J., de Jong S., and van Leeuwen P.A.M. Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography. Anal Biochem 303 (2002) 131-137
16. Pi J., Kumagai Y., Sun G., and Shimojo N. Improved method for simultaneous determination of l-arginine and its mono- and dimethylated metabolites in biological sample by high-performance liquid chromatography. J Chromatogr B 742 (2000) 199-203
17. G dimethylarginine in human plasma by high-performance liquid chromatography. J Chromatogr B 692 (1997) 467-471
18. Petterson A., Uggla L., and Backman V. Determination of dimethylated arginines in human plasma by high-performance liquid chromatography. J Chromatogr B 692 (1997) 257-262
19. Martens-Lobenhoffer J., and Bode-Böger S.M. Simultaneous determination of arginine, asymmetric dimethylarginine, symmetric dimethylarginine and citrulline in human plasma and urine applying liquid chromatography-mass spectrometry with very straightforward sample preparation. J Chromatogr B 798 (2003) 231-239
20. Kirchherr H., and Kühn-Velten W.N. HPLC-tandem mass spectrometric method for rapid quantification of dimethylarginines in human plasma. Clin Chem 51 (2005) 249-252
21. Schwedhelm E., Maas R., Tan-Andresen J., Schulze F., Riederer U., and Böger R.H. High-throughput liquid chromatographic-tandem mass spectrometric determination of arginine and dimethylated arginine derivatives in human and mouse plasma. J Chromatogr B 851 (2007) 211-219
22. Martens-Lobenhoffer J., and Bode- Böger S.M. Chromatographic-mass spectrometric methods for the quantification of l-arginine and its methylated metabolites in biological fluids. J Chromatogr B 851 (2007) 30-41
23. Bishop M.J., Crow B., Norton D., Paliakov E., George J., and Bralley J.A. Direct analysis of un-derivatised asymmetric dimethylarginine (ADMA) and l-arginine from plasma using mixed-mode ion-exchange liquid chromatography-tandem mass spectrometry. J Chromatogr B 859 (2007) 164-169
24. G dimethyl-l-arginine, an endogenous NO synthase inhibitor, by gas chromatography-mass spectrometry. J Chromatogr B 809 (2004) 59-65
25. Trapp G., Sydow K., Dulay M.T., Chou T., Cooke J.P., and Zare R.N. Capillary electrophoretic and micellar electrokinetic separations of asymmetric dimethyl-l-arginine and structurally related amino acids: quantitation in human plasma. J Sep Sci 27 (2004) 1483-1490
26. Schulze F., Wesemann R., Schwedhelm E., et al. Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay. Clin Chem Lab Med 42 (2004) 1377-1383
27. Blackwell S., O'Reilly D St J., and Talwar D. Biological variation of asymmetric dimethylarginine (ADMA) and related arginine metabolites and analytical performance goals for their measurement in human plasma. Eur J Clin Invest 37 (2007) 364-371
28. Fraser C.G., and Harris E.K. Generation and application of data on biological variation in clinical chemistry. Crit Rev Clin Lab Sci 27 (1989) 409-437
29. Hyltoft Petersen P., Fraser C.G., Jorgensen L., et al. Combination of analytical quality specifications based on biological within- and between-subject variation. Ann Clin Biochem 39 (2002) 543-550
30. Kielstein J.T., and Cooke J.P. Should we measure asymmetric dimethylarginine in patients with coronary artery disease?. Clin Chem 53 (2007) 161-163
31. Martens-Lobenhoffer J., Westphal S., Friedemann A., Bode-Böger S.M., and Luley C. Determination of asymmetric dimethylarginine: liquid chromatography-mass spectrometry or ELISA?. Clin Chem 51 (2005) 2188-2189
32. G monomethyl-l-arginine in human end-stage renal failure patients on regular haemodialysis. Exp Physiol 81 (1996) 475-481
33. Mizutani N., Hayakawa C., Ohya Y., Watanabe K., Watanabe Y., and Mori A. Guanidino compounds in hyperargininemia. Tohoku J Exp Med 153 (1987) 197-205
34. Meyer J., Richter N., and Hecker M. High performance liquid chromatographic determination of nitric oxide synthase related arginine derivatives in vitro and in vivo. Anal Biochem 247 (1997) 11-16
35. Pi J., Kumagai Y., Sun G., and Shimojo N. Improved method for simultaneous determination of l-arginine and its mono and dimethylated metabolites in biological samples by high-performance liquid chromatography. J Chromatogr B 742 (2000) 199-203
36. Meinitzer A., Puchinger M., Winklhofer-Roob B.M., et al. Reference values for plasma concentrations of asymmetrical dimethylarginine (ADMA) and other arginine metabolities in men after validation of a chromatographic method. Clin Chim Acta 384 (2007) 141-148
37. Beppu M., Obayashi S., Aso T., Goto M., and Azuma H. Endogenous nitric oxide synthase inhibitors in endothelial cells, endothelin-1 within the vessel wall, and intimal hyperplasia in perimenopausal human uterine arteries. J Cardiovasc Pharmacol 39 (2002) 192-200
38. Cardounel A.J., and Zweier J.L. Endogenous methylarginines regulate neuronal nitric-oxide synthase and prevent excitotoxic injury. J Biol Chem 277 (2002) 33995-34002
39. Mittermayer F., Namiranian K., Pleiner J., Schaller G., and Wolzt M. Acute Escherichia coli endotoxaemia decreases the plasma l-arginine/asymmetrical dimethylarginine ratio in humans. Clin Sci 106 (2004) 577-581
40. Bode- Böger S.M., Böger R.H., Kienke S., Junker W., and Frölich J.C. Elevated l-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary l-arginine in hypercholesterolaemic rabbits. Biochem Biophys Res Commun 219 (1996) 598-603
41. Teerlink T. Measurement of asymmetric dimethylarginine in plasma: methodological considerations and clinical relevance. Clin Chem Lab Med 43 (2005) 1130-1138
42. Horowitz J., and Heresztyn T. An overview of plasma concentrations of asymmetric dimethylarginine (ADMA) in health and disease and in clinical studies: methodological considerations. J Chromatogr B 851 (2007) 42-50
43. Teerlink T. HPLC analysis of ADMA and other methylated l-arginine analogs in biological fluids. J Chromatogr B 851 (2007) 21-29
44. G-dimethyl-l-arginine in 500 subjects. Eur J Clin Invest 35 (2005) 622-626